| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 1.60e-08 | 5 | 152 | 4 | GO:0005007 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 3.48e-05 | 49 | 152 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 4.70e-05 | 85 | 152 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 4.94e-05 | 27 | 152 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 4.94e-05 | 27 | 152 | 4 | GO:0017134 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 6.82e-05 | 11 | 152 | 3 | GO:0032395 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.37e-04 | 65 | 152 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | threonine-tRNA ligase activity | 1.72e-04 | 3 | 152 | 2 | GO:0004829 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.95e-04 | 156 | 152 | 7 | GO:0019838 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 2.63e-04 | 41 | 152 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 3.42e-04 | 4 | 152 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 4.48e-04 | 20 | 152 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | heparin binding | 6.82e-04 | 192 | 152 | 7 | GO:0008201 | |
| GeneOntologyMolecularFunction | netrin receptor activity | 8.46e-04 | 6 | 152 | 2 | GO:0005042 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | PDGFRA HLA-DRB1 HLA-DRB3 HLA-DRB5 GRM4 GRM8 PTPRT ADGRG6 MRGPRX1 UNC5C PLXNA4 CCR6 LTBP1 FGFR1 FGFR3 FGFR2 FGFR4 HTR3B OSMR UNC5D PLXNA2 | 1.43e-03 | 1353 | 152 | 21 | GO:0004888 |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor apoptotic signaling pathway | 4.08e-07 | 3 | 154 | 3 | GO:1902178 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 5.07e-06 | 16 | 154 | 4 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 5.07e-06 | 16 | 154 | 4 | GO:0002503 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 1.62e-05 | 21 | 154 | 4 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 1.62e-05 | 21 | 154 | 4 | GO:0002501 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.87e-05 | 48 | 154 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | limb bud formation | 3.32e-05 | 9 | 154 | 3 | GO:0060174 | |
| GeneOntologyBiologicalProcess | branching involved in salivary gland morphogenesis | 5.32e-05 | 28 | 154 | 4 | GO:0060445 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation involved in lung development | 5.54e-05 | 2 | 154 | 2 | GO:0060915 | |
| GeneOntologyBiologicalProcess | urothelial cell proliferation | 5.54e-05 | 2 | 154 | 2 | GO:0050674 | |
| GeneOntologyBiologicalProcess | regulation of urothelial cell proliferation | 5.54e-05 | 2 | 154 | 2 | GO:0050675 | |
| GeneOntologyBiologicalProcess | positive regulation of urothelial cell proliferation | 5.54e-05 | 2 | 154 | 2 | GO:0050677 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in mammary gland specification | 5.54e-05 | 2 | 154 | 2 | GO:0060595 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 5.54e-05 | 2 | 154 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | branch elongation involved in salivary gland morphogenesis | 5.54e-05 | 2 | 154 | 2 | GO:0060667 | |
| GeneOntologyBiologicalProcess | mammary gland bud formation | 5.54e-05 | 2 | 154 | 2 | GO:0060615 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 7.24e-05 | 58 | 154 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.13e-05 | 32 | 154 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | regulation of Ras protein signal transduction | 9.23e-05 | 61 | 154 | 5 | GO:0046578 | |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | HLA-DRB1 HLA-DRB3 HLA-E CD55 UFL1 ITGAM IGLL5 STAT5B LIG4 PLEKHM2 MRGPRX1 CCR6 C7 GNL1 | 1.10e-04 | 576 | 154 | 14 | GO:0002443 |
| GeneOntologyBiologicalProcess | lung saccule development | 1.10e-04 | 13 | 154 | 3 | GO:0060430 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immune response to tumor cell | 1.40e-04 | 14 | 154 | 3 | GO:0002840 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipase activity | 1.40e-04 | 14 | 154 | 3 | GO:0010518 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast growth factor production | 1.40e-04 | 14 | 154 | 3 | GO:0090270 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor production | 1.40e-04 | 14 | 154 | 3 | GO:0090269 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | HLA-DRB1 HLA-DRB3 HLA-E CD55 UFL1 IGLL5 STAT5B LIG4 PLEKHM2 CCR6 C7 GNL1 | 1.44e-04 | 449 | 154 | 12 | GO:0002449 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 1.46e-04 | 36 | 154 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | threonyl-tRNA aminoacylation | 1.65e-04 | 3 | 154 | 2 | GO:0006435 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 1.65e-04 | 3 | 154 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 1.65e-04 | 3 | 154 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | myeloid dendritic cell antigen processing and presentation | 1.65e-04 | 3 | 154 | 2 | GO:0002469 | |
| GeneOntologyBiologicalProcess | salivary gland morphogenesis | 1.81e-04 | 38 | 154 | 4 | GO:0007435 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.81e-04 | 38 | 154 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | mammary gland development | 2.19e-04 | 162 | 154 | 7 | GO:0030879 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 2.44e-04 | 41 | 154 | 4 | GO:0010092 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 2.44e-04 | 41 | 154 | 4 | GO:0060441 | |
| GeneOntologyBiologicalProcess | T cell mediated immune response to tumor cell | 2.57e-04 | 17 | 154 | 3 | GO:0002424 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 2.62e-04 | 76 | 154 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | salivary gland development | 2.94e-04 | 43 | 154 | 4 | GO:0007431 | |
| GeneOntologyBiologicalProcess | mammary gland specification | 3.29e-04 | 4 | 154 | 2 | GO:0060594 | |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 3.29e-04 | 4 | 154 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | mammary gland bud morphogenesis | 3.29e-04 | 4 | 154 | 2 | GO:0060648 | |
| GeneOntologyBiologicalProcess | positive regulation of parathyroid hormone secretion | 3.29e-04 | 4 | 154 | 2 | GO:2000830 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 4.03e-04 | 128 | 154 | 6 | GO:0007265 | |
| GeneOntologyBiologicalProcess | embryonic digestive tract morphogenesis | 4.92e-04 | 21 | 154 | 3 | GO:0048557 | |
| GeneOntologyBiologicalProcess | DN2 thymocyte differentiation | 5.46e-04 | 5 | 154 | 2 | GO:1904155 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 5.46e-04 | 5 | 154 | 2 | GO:0060665 | |
| GeneOntologyBiologicalProcess | regulation of parathyroid hormone secretion | 5.46e-04 | 5 | 154 | 2 | GO:2000828 | |
| GeneOntologyBiologicalProcess | regulation of phospholipase activity | 5.66e-04 | 22 | 154 | 3 | GO:0010517 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial fission | 5.66e-04 | 22 | 154 | 3 | GO:0090141 | |
| GeneOntologyBiologicalProcess | immune effector process | MPO HLA-DRB1 HLA-DRB3 HLA-E CD55 EVPL UFL1 ITGAM IGLL5 STAT5B LIG4 PLEKHM2 MRGPRX1 CCR6 C7 GNL1 | 7.11e-04 | 859 | 154 | 16 | GO:0002252 |
| GeneOntologyBiologicalProcess | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 8.15e-04 | 6 | 154 | 2 | GO:0090080 | |
| GeneOntologyBiologicalProcess | forebrain ventricular zone progenitor cell division | 8.15e-04 | 6 | 154 | 2 | GO:0021869 | |
| GeneOntologyBiologicalProcess | chemorepulsion of axon | 8.15e-04 | 6 | 154 | 2 | GO:0061643 | |
| GeneOntologyBiologicalProcess | positive regulation of lipase activity | 8.32e-04 | 25 | 154 | 3 | GO:0060193 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway | 8.45e-04 | 98 | 154 | 5 | GO:0008543 | |
| GeneOntologyBiologicalProcess | exocrine system development | 8.68e-04 | 57 | 154 | 4 | GO:0035272 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 8.85e-04 | 99 | 154 | 5 | GO:0032465 | |
| GeneOntologyBiologicalProcess | organ induction | 9.36e-04 | 26 | 154 | 3 | GO:0001759 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.18e-06 | 26 | 154 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | cell surface | TMIGD1 NRCAM PDGFRA HLA-DRB1 HLA-DRB5 HLA-E CD55 GPC6 ITGAM VWDE PTPRT ADGRG6 LMO7 MRGPRX1 UNC5C FGF10 CCR6 FGFR3 CAPN5 FGFR2 HTR3B OSMR CD99L2 UNC5D | 2.05e-06 | 1111 | 154 | 24 | GO:0009986 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 5.52e-06 | 35 | 154 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 6.26e-06 | 17 | 154 | 4 | GO:0042613 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 1.95e-05 | 112 | 154 | 7 | GO:0032588 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.70e-05 | 48 | 154 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.09e-04 | 64 | 154 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | autolysosome membrane | 3.20e-04 | 4 | 154 | 2 | GO:0120281 | |
| GeneOntologyCellularComponent | host intracellular region | 7.93e-04 | 6 | 154 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 7.93e-04 | 6 | 154 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 7.93e-04 | 6 | 154 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 7.93e-04 | 6 | 154 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 7.93e-04 | 6 | 154 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 7.93e-04 | 6 | 154 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 7.93e-04 | 6 | 154 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.08e-03 | 278 | 154 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.34e-03 | 110 | 154 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | ATP7B HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HLA-E ZFYVE1 KIF13A PLK3 VPS13B | 1.69e-03 | 443 | 154 | 10 | GO:0098791 |
| GeneOntologyCellularComponent | stereocilium | 1.69e-03 | 69 | 154 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | side of membrane | NRCAM PDGFRA HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HLA-E CD55 GPC6 ITGAM RGS1 CNTN3 CCR6 FGFR3 OSMR | 2.07e-03 | 875 | 154 | 15 | GO:0098552 |
| GeneOntologyCellularComponent | caspase complex | 2.33e-03 | 10 | 154 | 2 | GO:0008303 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 2.77e-03 | 79 | 154 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | stereocilium bundle | 2.77e-03 | 79 | 154 | 4 | GO:0032421 | |
| HumanPheno | Hypoplasia of the epiglottis | 1.28e-06 | 10 | 47 | 4 | HP:0005349 | |
| HumanPheno | Lacrimal gland aplasia | 2.93e-06 | 4 | 47 | 3 | HP:0007656 | |
| HumanPheno | Hypoplasia of the lacrimal punctum | 2.93e-06 | 4 | 47 | 3 | HP:0007892 | |
| HumanPheno | Abnormal lacrimal gland morphology | 4.28e-06 | 13 | 47 | 4 | HP:0011482 | |
| HumanPheno | Aplasia/Hypoplasia of the Epiglottis | 4.28e-06 | 13 | 47 | 4 | HP:0010565 | |
| HumanPheno | Short middle phalanx of toe | 7.27e-06 | 5 | 47 | 3 | HP:0003795 | |
| HumanPheno | Increased corneal thickness | 7.27e-06 | 5 | 47 | 3 | HP:0011487 | |
| HumanPheno | Decreased corneal sensation | 7.27e-06 | 5 | 47 | 3 | HP:0012155 | |
| HumanPheno | Absent lacrimal punctum | 2.51e-05 | 7 | 47 | 3 | HP:0001092 | |
| HumanPheno | Abnormal lacrimal punctum morphology | 3.99e-05 | 8 | 47 | 3 | HP:0011479 | |
| HumanPheno | Cloverleaf skull | 3.99e-05 | 8 | 47 | 3 | HP:0002676 | |
| HumanPheno | Limbal stem cell deficiency | 3.99e-05 | 8 | 47 | 3 | HP:0032107 | |
| HumanPheno | Abnormal epiglottis morphology | 4.96e-05 | 23 | 47 | 4 | HP:0005483 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 5.56e-05 | 150 | 47 | 8 | HP:0009601 | |
| HumanPheno | Keratoconjunctivitis sicca | 6.17e-05 | 47 | 47 | 5 | HP:0001097 | |
| HumanPheno | Abnormal salivary gland morphology | 8.20e-05 | 26 | 47 | 4 | HP:0010286 | |
| HumanPheno | Broad proximal phalanx of the hallux | 8.33e-05 | 2 | 47 | 2 | HP:0010086 | |
| HumanPheno | 3-4 toe cutaneous syndactyly | 8.33e-05 | 2 | 47 | 2 | HP:6000648 | |
| HumanPheno | Broad middle phalanges of the toes | 8.33e-05 | 2 | 47 | 2 | HP:0010195 | |
| HumanPheno | Calcaneonavicular fusion | 8.33e-05 | 2 | 47 | 2 | HP:0008122 | |
| HumanPheno | Tracheal cartilaginous sleeve | 8.33e-05 | 2 | 47 | 2 | HP:0005347 | |
| HumanPheno | Epiphora | 9.56e-05 | 27 | 47 | 4 | HP:0009926 | |
| HumanPheno | Keratoconjunctivitis | 1.01e-04 | 52 | 47 | 5 | HP:0001096 | |
| HumanPheno | Abnormality of the middle phalanges of the toes | 1.15e-04 | 11 | 47 | 3 | HP:0010183 | |
| HumanPheno | Aplastic/hypoplastic lacrimal glands | 1.15e-04 | 11 | 47 | 3 | HP:0008038 | |
| HumanPheno | Lacrimal duct aplasia | 1.15e-04 | 11 | 47 | 3 | HP:0007925 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 1.28e-04 | 87 | 47 | 6 | HP:0000614 | |
| HumanPheno | Xerostomia | 1.33e-04 | 55 | 47 | 5 | HP:0000217 | |
| HumanPheno | Short thumb | 1.39e-04 | 127 | 47 | 7 | HP:0009778 | |
| HumanPheno | Abnormality of the distal phalanx of the hallux | 1.53e-04 | 12 | 47 | 3 | HP:0010053 | |
| HumanPheno | Open angle glaucoma | 1.53e-04 | 12 | 47 | 3 | HP:0012108 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | PRRX1 NRCAM PDGFRA SMC1A OSGEP GPC6 STAMBP ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 PRORP CPLANE1 TARS1 VPS13B | 2.46e-04 | 915 | 47 | 19 | HP:0009116 |
| HumanPheno | Broad distal phalanx of the hallux | 2.49e-04 | 3 | 47 | 2 | HP:0010077 | |
| HumanPheno | Abnormal oral physiology | ATP7B HLA-DRB1 SMC1A ITGAM STAT5B FGF10 CCR6 FGFR1 FGFR3 FGFR2 HERC1 | 2.87e-04 | 355 | 47 | 11 | HP:0031815 |
| HumanPheno | Recurrent corneal erosions | 3.10e-04 | 15 | 47 | 3 | HP:0000495 | |
| HumanPheno | Hypotelorism | 3.31e-04 | 146 | 47 | 7 | HP:0000601 | |
| HumanPheno | Abnormal corpus callosum morphology | PRRX1 GALC NRCAM SMC1A OSGEP GCSH STAMBP LIG4 MACF1 IRF2BPL FGFR1 FGFR3 FGFR2 PRORP HERC1 CPLANE1 GMPPB TARS1 VPS13B | 3.38e-04 | 937 | 47 | 19 | HP:0001273 |
| HumanPheno | Narrow internal auditory canal | 3.79e-04 | 16 | 47 | 3 | HP:0011386 | |
| HumanPheno | Abnormality of thumb phalanx | 4.87e-04 | 205 | 47 | 8 | HP:0009602 | |
| HumanPheno | Duplication of the distal phalanx of the hallux | 4.94e-04 | 4 | 47 | 2 | HP:0010084 | |
| HumanPheno | Duplication of distal phalanx of toe | 4.94e-04 | 4 | 47 | 2 | HP:0010193 | |
| HumanPheno | Anomalous tracheal cartilage | 4.94e-04 | 4 | 47 | 2 | HP:0004468 | |
| HumanPheno | Lacrimal gland hypoplasia | 4.94e-04 | 4 | 47 | 2 | HP:0007732 | |
| HumanPheno | Abnormal hip bone morphology | NRCAM HLA-DRB1 SMC1A OSGEP ANKRD55 BRCA2 TRPM3 MACF1 CCR6 LTBP1 FGFR1 FGFR3 FGFR2 GMPPB VPS13B | 5.05e-04 | 653 | 47 | 15 | HP:0003272 |
| HumanPheno | Abnormal pelvic girdle bone morphology | NRCAM HLA-DRB1 SMC1A OSGEP GPC6 ANKRD55 BRCA2 TRPM3 MACF1 CCR6 LTBP1 FGFR1 FGFR3 FGFR2 GMPPB VPS13B | 5.22e-04 | 730 | 47 | 16 | HP:0002644 |
| HumanPheno | Upper airway obstruction | 5.45e-04 | 18 | 47 | 3 | HP:0002781 | |
| HumanPheno | Alacrima | 5.45e-04 | 18 | 47 | 3 | HP:0000522 | |
| HumanPheno | Broad hallux | 6.09e-04 | 76 | 47 | 5 | HP:0010055 | |
| HumanPheno | Dacryocystitis | 6.43e-04 | 19 | 47 | 3 | HP:0000620 | |
| HumanPheno | Ankylosis | 6.43e-04 | 19 | 47 | 3 | HP:0031013 | |
| HumanPheno | Triangular shaped phalanges of the hand | 6.49e-04 | 214 | 47 | 8 | HP:0009774 | |
| HumanPheno | Abnormality of salivation | 6.69e-04 | 215 | 47 | 8 | HP:0100755 | |
| HumanPheno | Retinal detachment | 6.72e-04 | 118 | 47 | 6 | HP:0000541 | |
| HumanPheno | Malaise | 7.19e-04 | 45 | 47 | 4 | HP:0033834 | |
| HumanPheno | Holoprosencephaly | 7.71e-04 | 80 | 47 | 5 | HP:0001360 | |
| HumanPheno | Typified by somatic mosaicism | 7.73e-04 | 168 | 47 | 7 | HP:0001442 | |
| HumanPheno | Somatic mutation | 7.73e-04 | 168 | 47 | 7 | HP:0001428 | |
| HumanPheno | Inflammatory abnormality of the eye | 7.79e-04 | 220 | 47 | 8 | HP:0100533 | |
| HumanPheno | Turricephaly | 7.82e-04 | 46 | 47 | 4 | HP:0000262 | |
| HumanPheno | Hypopigmented skin patches | 8.02e-04 | 122 | 47 | 6 | HP:0001053 | |
| HumanPheno | Broad distal phalanx of the toes | 8.19e-04 | 5 | 47 | 2 | HP:0010186 | |
| HumanPheno | Short first metatarsal | 8.19e-04 | 5 | 47 | 2 | HP:0010105 | |
| HumanPheno | Hallux varus | 8.19e-04 | 5 | 47 | 2 | HP:0008080 | |
| HumanPheno | Short long bone | 8.21e-04 | 278 | 47 | 9 | HP:0003026 | |
| HumanPheno | Abnormality of the jaws | PRRX1 NRCAM PDGFRA SMC1A OSGEP GPC6 ANKRD55 STAMBP ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 PRORP HERC1 CPLANE1 TARS1 VPS13B | 8.26e-04 | 1175 | 47 | 21 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | PRRX1 NRCAM PDGFRA SMC1A OSGEP GPC6 ANKRD55 STAMBP ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 PRORP HERC1 CPLANE1 TARS1 VPS13B | 8.36e-04 | 1176 | 47 | 21 | HP:0030791 |
| HumanPheno | Choanal atresia | 8.37e-04 | 123 | 47 | 6 | HP:0000453 | |
| HumanPheno | Aplasia/Hypoplasia of the radius | 8.63e-04 | 82 | 47 | 5 | HP:0006501 | |
| HumanPheno | Micrognathia | PRRX1 NRCAM SMC1A OSGEP GPC6 ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 PRORP CPLANE1 TARS1 VPS13B | 8.73e-04 | 843 | 47 | 17 | HP:0000347 |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | PRRX1 NRCAM PDGFRA SMC1A OSGEP GPC6 STAMBP ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 PRORP CPLANE1 TARS1 VPS13B | 8.81e-04 | 1008 | 47 | 19 | HP:0009122 |
| HumanPheno | Heterotropia | 8.87e-04 | 281 | 47 | 9 | HP:0032012 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | PRRX1 NRCAM SMC1A OSGEP GPC6 ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 PRORP CPLANE1 TARS1 VPS13B | 8.98e-04 | 845 | 47 | 17 | HP:0009118 |
| HumanPheno | Abnormal thumb morphology | SMC1A OSGEP ADGRG6 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 CPLANE1 | 9.42e-04 | 408 | 47 | 11 | HP:0001172 |
| HumanPheno | Cyclopia | 1.00e-03 | 22 | 47 | 3 | HP:0009914 | |
| HumanPheno | Abnormality of the internal auditory canal | 1.00e-03 | 22 | 47 | 3 | HP:0011384 | |
| HumanPheno | Corneal ulceration | 1.00e-03 | 22 | 47 | 3 | HP:0012804 | |
| HumanPheno | Anosmia | 1.07e-03 | 50 | 47 | 4 | HP:0000458 | |
| HumanPheno | patches | 1.08e-03 | 129 | 47 | 6 | HP:0200033 | |
| HumanPheno | Abnormal upper limb bone morphology | SMC1A GPC6 ANKRD55 LIG4 BRCA2 TRPM3 FGF10 FGFR1 FGFR3 FGFR2 CPLANE1 VPS13B | 1.11e-03 | 484 | 47 | 12 | HP:0040070 |
| HumanPheno | Abnormality of lower limb joint | GALC NRCAM HLA-DRB1 SMC1A CAPN1 OSGEP GCSH GPC6 ANKRD55 BRCA2 TRPM3 MACF1 CCR6 LTBP1 FGFR1 FGFR3 FGFR2 GMPPB VPS13B | 1.12e-03 | 1027 | 47 | 19 | HP:0100491 |
| HumanPheno | Hypoplasia of the maxilla | 1.12e-03 | 130 | 47 | 6 | HP:0000327 | |
| HumanPheno | Broad toe | 1.13e-03 | 87 | 47 | 5 | HP:0001837 | |
| HumanPheno | Abnormal cerebral white matter morphology | PRRX1 GALC NRCAM SMC1A OSGEP GCSH STAMBP LIG4 TRPM3 MACF1 IRF2BPL FGFR1 FGFR3 FGFR2 PRORP HERC1 CPLANE1 GMPPB TARS1 VPS13B | 1.13e-03 | 1114 | 47 | 20 | HP:0002500 |
| HumanPheno | Abnormal periventricular white matter morphology | 1.21e-03 | 132 | 47 | 6 | HP:0002518 | |
| HumanPheno | Narrow foramen obturatorium | 1.22e-03 | 6 | 47 | 2 | HP:0100958 | |
| HumanPheno | Broad first metatarsal | 1.22e-03 | 6 | 47 | 2 | HP:0010068 | |
| HumanPheno | Abnormal morphology of the proximal phalanx of the hallux | 1.22e-03 | 6 | 47 | 2 | HP:0010052 | |
| HumanPheno | Broad proximal phalanx of toe | 1.22e-03 | 6 | 47 | 2 | HP:0010204 | |
| HumanPheno | Proximal radio-ulnar synostosis | 1.22e-03 | 6 | 47 | 2 | HP:0005037 | |
| HumanPheno | Hydrocephalus | GALC NRCAM SMC1A LIG4 BRCA2 FGFR1 FGFR3 FGFR2 HERC1 CPLANE1 GMPPB | 1.22e-03 | 421 | 47 | 11 | HP:0000238 |
| HumanPheno | Abnormal hip joint morphology | NRCAM SMC1A OSGEP ANKRD55 BRCA2 TRPM3 MACF1 LTBP1 FGFR1 FGFR3 FGFR2 GMPPB | 1.24e-03 | 490 | 47 | 12 | HP:0001384 |
| HumanPheno | Scoliosis | GALC NRCAM SMC1A CAPN1 ADGRG6 TUBGCP6 LIG4 BRCA2 TRPM3 FGF10 LTBP1 FGFR1 FGFR3 FGFR2 PRORP HERC1 MAPKBP1 CPLANE1 GMPPB VPS13B | 1.24e-03 | 1122 | 47 | 20 | HP:0002650 |
| HumanPheno | Bicornuate uterus | 1.25e-03 | 52 | 47 | 4 | HP:0000813 | |
| HumanPheno | Aplasia/Hypoplasia of the maxilla | 1.26e-03 | 133 | 47 | 6 | HP:0009117 | |
| HumanPheno | Aplasia/Hypoplasia of the nares | 1.30e-03 | 24 | 47 | 3 | HP:0100597 | |
| HumanPheno | Choanal atresia or stenosis | 1.31e-03 | 134 | 47 | 6 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 1.31e-03 | 134 | 47 | 6 | HP:0000415 | |
| HumanPheno | Broad thumb | 1.32e-03 | 90 | 47 | 5 | HP:0011304 | |
| HumanPheno | Keratitis | 1.32e-03 | 90 | 47 | 5 | HP:0000491 | |
| HumanPheno | Dysphagia | GALC ATP7B PDGFRA HLA-DRB1 SMC1A TAMM41 MACF1 IRF2BPL FGF10 CCR6 FGFR1 FGFR3 FGFR2 | 1.37e-03 | 567 | 47 | 13 | HP:0002015 |
| MousePheno | small otic capsule | 3.78e-05 | 8 | 125 | 3 | MP:0006288 | |
| MousePheno | cecal atresia | 7.93e-05 | 2 | 125 | 2 | MP:0009510 | |
| MousePheno | absent colon | 7.93e-05 | 2 | 125 | 2 | MP:0011884 | |
| MousePheno | absent palatal rugae | 7.93e-05 | 2 | 125 | 2 | MP:0013766 | |
| MousePheno | premature facial suture closure | 7.93e-05 | 2 | 125 | 2 | MP:0030390 | |
| MousePheno | long limbs | 7.93e-05 | 2 | 125 | 2 | MP:0000548 | |
| MousePheno | perineal hypospadia | 7.93e-05 | 2 | 125 | 2 | MP:0031300 | |
| MousePheno | abnormal cecum development | 7.93e-05 | 2 | 125 | 2 | MP:0009479 | |
| MousePheno | abnormal lateral plate mesoderm morphology | 1.09e-04 | 11 | 125 | 3 | MP:0010117 | |
| MousePheno | abnormal pulmonary vein morphology | 1.87e-04 | 13 | 125 | 3 | MP:0002726 | |
| MousePheno | absent limb buds | 1.87e-04 | 13 | 125 | 3 | MP:0004573 | |
| MousePheno | abnormal sphenoid bone morphology | 2.06e-04 | 95 | 125 | 6 | MP:0000104 | |
| MousePheno | abnormal forelimb morphology | 2.28e-04 | 182 | 125 | 8 | MP:0000550 | |
| MousePheno | abnormal CD11b-high dendritic cell number | 2.36e-04 | 14 | 125 | 3 | MP:0013647 | |
| MousePheno | premature intramembranous bone ossification | 2.36e-04 | 14 | 125 | 3 | MP:0003418 | |
| MousePheno | abnormal pulmonary trunk morphology | 2.36e-04 | 14 | 125 | 3 | MP:0000486 | |
| MousePheno | premature cranial suture closure | 2.36e-04 | 14 | 125 | 3 | MP:0000081 | |
| MousePheno | premature craniofacial suture closure | 2.36e-04 | 14 | 125 | 3 | MP:0030435 | |
| MousePheno | absent rectum | 2.37e-04 | 3 | 125 | 2 | MP:0009509 | |
| MousePheno | absent pulmonary artery | 2.37e-04 | 3 | 125 | 2 | MP:0010521 | |
| MousePheno | absent pulmonary vein | 2.37e-04 | 3 | 125 | 2 | MP:0010646 | |
| MousePheno | abnormal mammary placode morphology | 2.37e-04 | 3 | 125 | 2 | MP:0013721 | |
| MousePheno | absent forelimb | 2.37e-04 | 3 | 125 | 2 | MP:0000551 | |
| MousePheno | enlarged allantois | 2.94e-04 | 15 | 125 | 3 | MP:0004556 | |
| MousePheno | long incisors | 3.59e-04 | 16 | 125 | 3 | MP:0004831 | |
| MousePheno | macrodontia | 3.59e-04 | 16 | 125 | 3 | MP:0030091 | |
| MousePheno | midface hypoplasia | 4.33e-04 | 17 | 125 | 3 | MP:0012085 | |
| MousePheno | abnormal nose morphology | 4.45e-04 | 201 | 125 | 8 | MP:0002233 | |
| MousePheno | abnormal submandibular duct morphology | 4.70e-04 | 4 | 125 | 2 | MP:0009525 | |
| MousePheno | abnormal branching involved in trachea morphogenesis | 4.70e-04 | 4 | 125 | 2 | MP:0011025 | |
| MousePheno | abnormal acromion morphology | 4.70e-04 | 4 | 125 | 2 | MP:0004345 | |
| MousePheno | abnormal facial suture morphology | 4.70e-04 | 4 | 125 | 2 | MP:0030230 | |
| MousePheno | absent zygomatic bone | 4.70e-04 | 4 | 125 | 2 | MP:0004467 | |
| MousePheno | premature metopic suture closure | 4.70e-04 | 4 | 125 | 2 | MP:0030367 | |
| MousePheno | abnormal palatal length | 4.70e-04 | 4 | 125 | 2 | MP:0003764 | |
| MousePheno | decreased palatal length | 4.70e-04 | 4 | 125 | 2 | MP:0003760 | |
| MousePheno | abnormal lateral nasal gland morphology | 4.70e-04 | 4 | 125 | 2 | MP:0013582 | |
| MousePheno | abnormal zygomatic bone morphology | 4.78e-04 | 41 | 125 | 4 | MP:0005270 | |
| MousePheno | face hypoplasia | 6.09e-04 | 19 | 125 | 3 | MP:0030065 | |
| MousePheno | abnormal hindlimb morphology | PRRX1 GALC TMPRSS6 CYP26A1 STARD10 GPC6 EMSY ADGRG6 FGF10 FGFR1 FGFR3 FGFR2 GNL1 MYBPC2 | 6.31e-04 | 576 | 125 | 14 | MP:0000556 |
| MousePheno | abnormal palatine bone morphology | 7.44e-04 | 46 | 125 | 4 | MP:0005249 | |
| MousePheno | abnormal palatal shelf morphology | 7.53e-04 | 121 | 125 | 6 | MP:0031460 | |
| MousePheno | absent lungs | 7.79e-04 | 5 | 125 | 2 | MP:0001181 | |
| MousePheno | submandibular gland hypoplasia | 7.79e-04 | 5 | 125 | 2 | MP:0009522 | |
| MousePheno | abnormal primitive urogenital sinus morphology | 7.79e-04 | 5 | 125 | 2 | MP:0010116 | |
| MousePheno | tongue ankylosis | 7.79e-04 | 5 | 125 | 2 | MP:0013264 | |
| MousePheno | absent hindlimb | 7.79e-04 | 5 | 125 | 2 | MP:0000557 | |
| MousePheno | abnormal stapes crus morpholgy | 7.79e-04 | 5 | 125 | 2 | MP:0030407 | |
| MousePheno | wide sternum | 7.79e-04 | 5 | 125 | 2 | MP:0012279 | |
| MousePheno | abnormal otic capsule morphology | 8.25e-04 | 21 | 125 | 3 | MP:0000039 | |
| MousePheno | abnormal secondary palate development | 8.57e-04 | 124 | 125 | 6 | MP:0009655 | |
| Domain | - | TMIGD1 MXRA5 NRCAM PDGFRA HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HLA-E FSD2 PKHD1L1 IGLL5 PTPRT MFAP3L LRRN3 FNDC7 UNC5C PLXNA4 CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 OSMR UNC5D PLXNA2 ALPK2 MYBPC2 | 9.21e-13 | 663 | 154 | 28 | 2.60.40.10 |
| Domain | Ig-like_fold | TMIGD1 MXRA5 NRCAM PDGFRA HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HLA-E FSD2 PKHD1L1 IGLL5 PTPRT MFAP3L LRRN3 FNDC7 UNC5C PLXNA4 CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 OSMR UNC5D PLXNA2 ALPK2 MYBPC2 | 4.15e-12 | 706 | 154 | 28 | IPR013783 |
| Domain | Ig_I-set | TMIGD1 MXRA5 NRCAM PDGFRA MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 5.30e-11 | 190 | 154 | 15 | IPR013098 |
| Domain | I-set | TMIGD1 MXRA5 NRCAM PDGFRA MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 5.30e-11 | 190 | 154 | 15 | PF07679 |
| Domain | IG_LIKE | TMIGD1 MXRA5 NRCAM PDGFRA HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HLA-E IGLL5 PTPRT MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 1.07e-10 | 491 | 154 | 22 | PS50835 |
| Domain | Ig-like_dom | TMIGD1 MXRA5 NRCAM PDGFRA HLA-DRB1 HLA-DRB3 HLA-DRB4 HLA-DRB5 HLA-E IGLL5 PTPRT MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 1.69e-10 | 503 | 154 | 22 | IPR007110 |
| Domain | IGc2 | TMIGD1 MXRA5 NRCAM PDGFRA MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 1.05e-09 | 235 | 154 | 15 | SM00408 |
| Domain | Ig_sub2 | TMIGD1 MXRA5 NRCAM PDGFRA MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 1.05e-09 | 235 | 154 | 15 | IPR003598 |
| Domain | FGF_rcpt_fam | 4.45e-09 | 4 | 154 | 4 | IPR016248 | |
| Domain | MHC_II_b_N | 3.03e-07 | 8 | 154 | 4 | PD000328 | |
| Domain | IG | TMIGD1 MXRA5 NRCAM PDGFRA PTPRT MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 4.17e-07 | 421 | 154 | 16 | SM00409 |
| Domain | Ig_sub | TMIGD1 MXRA5 NRCAM PDGFRA PTPRT MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 4.17e-07 | 421 | 154 | 16 | IPR003599 |
| Domain | Ig/MHC_CS | 4.78e-07 | 58 | 154 | 7 | IPR003006 | |
| Domain | MHC_II_b_N | 5.42e-07 | 9 | 154 | 4 | IPR000353 | |
| Domain | MHC_II_beta | 5.42e-07 | 9 | 154 | 4 | SM00921 | |
| Domain | MHC_II_beta | 5.42e-07 | 9 | 154 | 4 | PF00969 | |
| Domain | IG_MHC | 6.05e-07 | 60 | 154 | 7 | PS00290 | |
| Domain | MHC_II_a/b_N | 4.17e-06 | 14 | 154 | 4 | IPR014745 | |
| Domain | - | 4.17e-06 | 14 | 154 | 4 | 3.10.320.10 | |
| Domain | C1-set | 5.31e-06 | 54 | 154 | 6 | PF07654 | |
| Domain | IGc1 | 6.59e-06 | 56 | 154 | 6 | SM00407 | |
| Domain | Ig_C1-set | 8.10e-06 | 58 | 154 | 6 | IPR003597 | |
| Domain | MHC_I/II-like_Ag-recog | 1.44e-05 | 38 | 154 | 5 | IPR011162 | |
| Domain | fn3 | 6.02e-05 | 162 | 154 | 8 | PF00041 | |
| Domain | FN3 | 1.52e-04 | 185 | 154 | 8 | SM00060 | |
| Domain | PROTEIN_KINASE_TYR | 1.52e-04 | 97 | 154 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.52e-04 | 97 | 154 | 6 | IPR008266 | |
| Domain | ig | 1.82e-04 | 190 | 154 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.82e-04 | 190 | 154 | 8 | IPR013151 | |
| Domain | ThrRS_core | 2.02e-04 | 3 | 154 | 2 | IPR033728 | |
| Domain | Thr-tRNA-ligase_IIa | 2.02e-04 | 3 | 154 | 2 | IPR002320 | |
| Domain | - | 2.02e-04 | 3 | 154 | 2 | 4.10.1130.10 | |
| Domain | FN3 | 2.50e-04 | 199 | 154 | 8 | PS50853 | |
| Domain | VWF_type-D | 2.85e-04 | 16 | 154 | 3 | IPR001846 | |
| Domain | VWFD | 2.85e-04 | 16 | 154 | 3 | PS51233 | |
| Domain | VWD | 2.85e-04 | 16 | 154 | 3 | SM00216 | |
| Domain | VWD | 2.85e-04 | 16 | 154 | 3 | PF00094 | |
| Domain | FN3_dom | 3.47e-04 | 209 | 154 | 8 | IPR003961 | |
| Domain | Kinesin-like_KIF1-typ | 4.01e-04 | 4 | 154 | 2 | IPR022140 | |
| Domain | KIF1B | 4.01e-04 | 4 | 154 | 2 | PF12423 | |
| Domain | UPA | 6.65e-04 | 5 | 154 | 2 | PF17217 | |
| Domain | UPA | 6.65e-04 | 5 | 154 | 2 | IPR033772 | |
| Domain | Tyr_kinase_cat_dom | 8.07e-04 | 88 | 154 | 5 | IPR020635 | |
| Domain | Rho_GTPase_activation_prot | 8.07e-04 | 88 | 154 | 5 | IPR008936 | |
| Domain | TyrKc | 8.07e-04 | 88 | 154 | 5 | SM00219 | |
| Domain | Kinesin_assoc | 9.91e-04 | 6 | 154 | 2 | PF16183 | |
| Domain | - | 9.91e-04 | 6 | 154 | 2 | 3.90.1290.10 | |
| Domain | TGS | 9.91e-04 | 6 | 154 | 2 | IPR004095 | |
| Domain | TGS | 9.91e-04 | 6 | 154 | 2 | PF02824 | |
| Domain | Kinesin-like | 9.91e-04 | 6 | 154 | 2 | IPR022164 | |
| Domain | Kinesin_assoc | 9.91e-04 | 6 | 154 | 2 | IPR032405 | |
| Domain | DUF3694 | 9.91e-04 | 6 | 154 | 2 | PF12473 | |
| Domain | tRNA_SAD | 1.38e-03 | 7 | 154 | 2 | IPR012947 | |
| Domain | Plectin | 1.38e-03 | 7 | 154 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.38e-03 | 7 | 154 | 2 | IPR001101 | |
| Domain | TGS-like | 1.38e-03 | 7 | 154 | 2 | IPR012676 | |
| Domain | tRNA_SAD | 1.38e-03 | 7 | 154 | 2 | SM00863 | |
| Domain | PLEC | 1.38e-03 | 7 | 154 | 2 | SM00250 | |
| Domain | tRNA_SAD | 1.38e-03 | 7 | 154 | 2 | PF07973 | |
| Domain | IPT | 1.39e-03 | 27 | 154 | 3 | SM00429 | |
| Domain | GPCR_3_mtglu_rcpt | 1.83e-03 | 8 | 154 | 2 | IPR000162 | |
| Domain | Thr/Ala-tRNA-synth_IIc_edit | 1.83e-03 | 8 | 154 | 2 | IPR018163 | |
| Domain | TIG | 2.09e-03 | 31 | 154 | 3 | PF01833 | |
| Domain | IPT | 2.29e-03 | 32 | 154 | 3 | IPR002909 | |
| Domain | BTK | 2.34e-03 | 9 | 154 | 2 | SM00107 | |
| Domain | Plexin_cytopl | 2.34e-03 | 9 | 154 | 2 | PF08337 | |
| Domain | ZU5 | 2.34e-03 | 9 | 154 | 2 | SM00218 | |
| Domain | Znf_Btk_motif | 2.34e-03 | 9 | 154 | 2 | IPR001562 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.34e-03 | 9 | 154 | 2 | IPR013548 | |
| Domain | Plexin | 2.34e-03 | 9 | 154 | 2 | IPR031148 | |
| Domain | BTK | 2.34e-03 | 9 | 154 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.34e-03 | 9 | 154 | 2 | PS51113 | |
| Domain | HGTP_anticodon | 2.34e-03 | 9 | 154 | 2 | PF03129 | |
| Domain | GBP_C | 2.91e-03 | 10 | 154 | 2 | PF02841 | |
| Domain | ZU5 | 2.91e-03 | 10 | 154 | 2 | PS51145 | |
| Domain | aa-tRNA-synt_IIb | 3.54e-03 | 11 | 154 | 2 | IPR002314 | |
| Domain | G_GB1_RHD3_dom | 3.54e-03 | 11 | 154 | 2 | IPR030386 | |
| Domain | - | 3.54e-03 | 11 | 154 | 2 | 3.40.50.800 | |
| Domain | Guanylate-bd_N | 3.54e-03 | 11 | 154 | 2 | IPR015894 | |
| Domain | tRNA-synt_2b | 3.54e-03 | 11 | 154 | 2 | PF00587 | |
| Domain | Guanylate-bd_C | 3.54e-03 | 11 | 154 | 2 | IPR003191 | |
| Domain | GBP | 3.54e-03 | 11 | 154 | 2 | PF02263 | |
| Domain | G_GB1_RHD3 | 3.54e-03 | 11 | 154 | 2 | PS51715 | |
| Domain | calpain_III | 4.22e-03 | 12 | 154 | 2 | SM00720 | |
| Domain | C2_III | 4.22e-03 | 12 | 154 | 2 | IPR033883 | |
| Domain | C8 | 4.22e-03 | 12 | 154 | 2 | PF08742 | |
| Domain | TIL | 4.22e-03 | 12 | 154 | 2 | PF01826 | |
| Domain | Calpain_III | 4.22e-03 | 12 | 154 | 2 | IPR022683 | |
| Domain | ZU5 | 4.22e-03 | 12 | 154 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.22e-03 | 12 | 154 | 2 | IPR000906 | |
| Domain | Pkinase_Tyr | 4.33e-03 | 129 | 154 | 5 | PF07714 | |
| Domain | Calpain_III | 4.96e-03 | 13 | 154 | 2 | PF01067 | |
| Domain | Unchr_dom_Cys-rich | 4.96e-03 | 13 | 154 | 2 | IPR014853 | |
| Domain | NCD3G | 4.96e-03 | 13 | 154 | 2 | PF07562 | |
| Domain | Calpain_domain_III | 4.96e-03 | 13 | 154 | 2 | IPR022682 | |
| Domain | C8 | 4.96e-03 | 13 | 154 | 2 | SM00832 | |
| Domain | GPCR_3_9-Cys_dom | 4.96e-03 | 13 | 154 | 2 | IPR011500 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 5.75e-03 | 138 | 154 | 5 | IPR001245 | |
| Domain | RasGAP | 5.76e-03 | 14 | 154 | 2 | SM00323 | |
| Domain | TIL_dom | 5.76e-03 | 14 | 154 | 2 | IPR002919 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 1.47e-06 | 11 | 118 | 4 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 1.47e-06 | 11 | 118 | 4 | M22048 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.75e-06 | 25 | 118 | 5 | M47934 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.87e-06 | 70 | 118 | 7 | M12294 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 3.15e-06 | 13 | 118 | 4 | M18928 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 4.38e-06 | 14 | 118 | 4 | M22023 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 4.38e-06 | 14 | 118 | 4 | M10765 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 4.38e-06 | 14 | 118 | 4 | M1473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 5.39e-06 | 31 | 118 | 5 | M47396 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 5.93e-06 | 15 | 118 | 4 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 5.93e-06 | 15 | 118 | 4 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 5.93e-06 | 15 | 118 | 4 | M7298 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 6.28e-06 | 55 | 118 | 6 | M47952 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 9.41e-06 | 89 | 118 | 7 | M39398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 1.00e-05 | 35 | 118 | 5 | M47379 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.33e-05 | 37 | 118 | 5 | M18615 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 1.39e-05 | 63 | 118 | 6 | M635 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 1.78e-05 | 98 | 118 | 7 | M965 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 2.22e-05 | 41 | 118 | 5 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.82e-05 | 43 | 118 | 5 | M12617 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 3.04e-05 | 22 | 118 | 4 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 3.04e-05 | 22 | 118 | 4 | M1467 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 3.65e-05 | 23 | 118 | 4 | M6705 | |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 3.76e-05 | 110 | 118 | 7 | M27162 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 4.85e-05 | 48 | 118 | 5 | M26916 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 6.76e-05 | 83 | 118 | 6 | M27163 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 6.76e-05 | 83 | 118 | 6 | M47961 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 7.16e-05 | 52 | 118 | 5 | M13103 | |
| Pathway | REACTOME_PD_1_SIGNALING | 8.18e-05 | 28 | 118 | 4 | M18810 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 8.60e-05 | 54 | 118 | 5 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 8.60e-05 | 54 | 118 | 5 | M620 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 8.80e-05 | 87 | 118 | 6 | M6856 | |
| Pathway | PID_FGF_PATHWAY | 9.40e-05 | 55 | 118 | 5 | M276 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 9.42e-05 | 29 | 118 | 4 | M6910 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR | 9.99e-05 | 89 | 118 | 6 | M1090 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 9.99e-05 | 89 | 118 | 6 | M47963 | |
| Pathway | KEGG_ASTHMA | 1.08e-04 | 30 | 118 | 4 | M13950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 1.20e-04 | 92 | 118 | 6 | M47927 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.26e-04 | 133 | 118 | 7 | M16476 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 3.06e-04 | 39 | 118 | 4 | M16523 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 3.38e-04 | 72 | 118 | 5 | M3126 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 3.72e-04 | 41 | 118 | 4 | MM14505 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 4.25e-04 | 116 | 118 | 6 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 4.45e-04 | 117 | 118 | 6 | M39530 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 4.65e-04 | 118 | 118 | 6 | M713 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 5.32e-04 | 121 | 118 | 6 | M39823 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 6.16e-04 | 82 | 118 | 5 | M1021 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 6.30e-04 | 47 | 118 | 4 | MM14885 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 6.83e-04 | 48 | 118 | 4 | MM15441 | |
| Pathway | KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION | 6.83e-04 | 48 | 118 | 4 | M615 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 7.98e-04 | 50 | 118 | 4 | M48087 | |
| Pathway | KEGG_ENDOCYTOSIS | 8.15e-04 | 181 | 118 | 7 | M1519 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 8.50e-04 | 88 | 118 | 5 | M16004 | |
| Pathway | WP_RAS_SIGNALING | 8.98e-04 | 184 | 118 | 7 | M39764 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.38e-03 | 98 | 118 | 5 | M39830 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.63e-03 | 150 | 118 | 6 | M39520 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.63e-03 | 325 | 118 | 9 | M12868 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.67e-03 | 326 | 118 | 9 | MM15917 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.74e-03 | 152 | 118 | 6 | MM15834 | |
| Pathway | REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS | 1.88e-03 | 8 | 118 | 2 | M27328 | |
| Pathway | REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION | 1.88e-03 | 8 | 118 | 2 | M27063 | |
| Pathway | REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION | 1.88e-03 | 8 | 118 | 2 | MM14725 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 1.90e-03 | 63 | 118 | 4 | M39623 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.95e-03 | 106 | 118 | 5 | M42535 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 2.08e-03 | 213 | 118 | 7 | M18306 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.17e-03 | 339 | 118 | 9 | M39736 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 2.41e-03 | 9 | 118 | 2 | M47397 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 2.41e-03 | 9 | 118 | 2 | MM15030 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 2.58e-03 | 113 | 118 | 5 | MM14783 | |
| Pubmed | 1.70e-12 | 5 | 156 | 5 | 27206683 | ||
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 3.89e-10 | 4 | 156 | 4 | 3476943 | |
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 9212826 | ||
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 3.89e-10 | 4 | 156 | 4 | 36142417 | |
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 11759058 | ||
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 12644244 | ||
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 9664689 | ||
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 26740600 | ||
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 27154171 | ||
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 3.89e-10 | 4 | 156 | 4 | 12144077 | |
| Pubmed | 3.89e-10 | 4 | 156 | 4 | 18520346 | ||
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 3.89e-10 | 4 | 156 | 4 | 12373339 | |
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 3.89e-10 | 4 | 156 | 4 | 18776942 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 3.89e-10 | 4 | 156 | 4 | 17304337 | |
| Pubmed | Regulation of external genitalia development by concerted actions of FGF ligands and FGF receptors. | 4.21e-10 | 10 | 156 | 5 | 15340846 | |
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 1.94e-09 | 5 | 156 | 4 | 15987787 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 1.94e-09 | 5 | 156 | 4 | 27078042 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 1.94e-09 | 5 | 156 | 4 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 1.94e-09 | 5 | 156 | 4 | 21633168 | |
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 17910142 | ||
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 16973583 | ||
| Pubmed | Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. | 1.94e-09 | 5 | 156 | 4 | 1970352 | |
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 7645219 | ||
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 12392858 | ||
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 12209103 | ||
| Pubmed | HLA-DQA is associated with abdominal aortic aneurysms in the Belgian population. | 1.94e-09 | 5 | 156 | 4 | 17182961 | |
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 11782380 | ||
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 1.94e-09 | 5 | 156 | 4 | 9771645 | |
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 28094278 | ||
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 23152536 | ||
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 17411376 | ||
| Pubmed | Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. | 1.94e-09 | 5 | 156 | 4 | 17507489 | |
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 7734415 | ||
| Pubmed | Visual hallucinations and HLA class II antigens in cortical dementia. | 1.94e-09 | 5 | 156 | 4 | 20606439 | |
| Pubmed | HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. | 1.94e-09 | 5 | 156 | 4 | 12144632 | |
| Pubmed | 1.94e-09 | 5 | 156 | 4 | 9013630 | ||
| Pubmed | HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line. | 1.94e-09 | 5 | 156 | 4 | 12202216 | |
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 1.94e-09 | 5 | 156 | 4 | 11566361 | |
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 10572038 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 17153701 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 18305173 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 15902698 | ||
| Pubmed | HLA risk markers for chronic myelogenous leukemia in Eastern Canada. | 5.80e-09 | 6 | 156 | 4 | 19235017 | |
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 5.80e-09 | 6 | 156 | 4 | 24026051 | |
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 11082517 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 15896200 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 9010207 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 16365308 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 5.80e-09 | 6 | 156 | 4 | 16436388 | |
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 19232523 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 29720668 | ||
| Pubmed | 5.80e-09 | 6 | 156 | 4 | 11997714 | ||
| Pubmed | HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. | 5.80e-09 | 6 | 156 | 4 | 14508706 | |
| Pubmed | 7.15e-09 | 16 | 156 | 5 | 11731698 | ||
| Pubmed | 1.35e-08 | 7 | 156 | 4 | 18569076 | ||
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 1.35e-08 | 7 | 156 | 4 | 20131355 | |
| Pubmed | 1.35e-08 | 7 | 156 | 4 | 1905983 | ||
| Pubmed | Human macrophages accumulate HIV-1 particles in MHC II compartments. | 1.35e-08 | 7 | 156 | 4 | 12230470 | |
| Pubmed | 1.35e-08 | 7 | 156 | 4 | 16772167 | ||
| Pubmed | 1.35e-08 | 7 | 156 | 4 | 8959336 | ||
| Pubmed | [Human leukocyte antigen genes to genetic predisposition in diffuse panbronchiolitis]. | 1.35e-08 | 7 | 156 | 4 | 18846964 | |
| Pubmed | 1.35e-08 | 7 | 156 | 4 | 20307907 | ||
| Pubmed | Fgf21 regulates T-cell development in the neonatal and juvenile thymus. | 1.39e-08 | 18 | 156 | 5 | 28336912 | |
| Pubmed | 2.50e-08 | 20 | 156 | 5 | 12427289 | ||
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 19223392 | ||
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 12966207 | ||
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 18187602 | ||
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 17623664 | ||
| Pubmed | Correlation between HLA and pityriasis rosea susceptibility in Brazilian blacks. | 2.69e-08 | 8 | 156 | 4 | 16405603 | |
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 12296785 | ||
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 17106278 | ||
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 2.69e-08 | 8 | 156 | 4 | 16989989 | |
| Pubmed | 2.69e-08 | 8 | 156 | 4 | 23729440 | ||
| Pubmed | 3.27e-08 | 21 | 156 | 5 | 11751963 | ||
| Pubmed | 3.27e-08 | 21 | 156 | 5 | 10579907 | ||
| Pubmed | 3.27e-08 | 21 | 156 | 5 | 8084338 | ||
| Pubmed | Expression of members of the Fgf family and their receptors during midfacial development. | 4.22e-08 | 22 | 156 | 5 | 11165488 | |
| Pubmed | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. | 4.82e-08 | 9 | 156 | 4 | 15830353 | |
| Pubmed | 4.82e-08 | 9 | 156 | 4 | 17164422 | ||
| Pubmed | Dynamic activation of Wnt, Fgf, and Hh signaling during soft palate development. | 4.82e-08 | 9 | 156 | 4 | 31613912 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 4.82e-08 | 9 | 156 | 4 | 10751173 | |
| Pubmed | 4.82e-08 | 9 | 156 | 4 | 24505475 | ||
| Pubmed | 4.82e-08 | 9 | 156 | 4 | 23170932 | ||
| Pubmed | 4.82e-08 | 9 | 156 | 4 | 11335076 | ||
| Pubmed | 4.82e-08 | 9 | 156 | 4 | 15229180 | ||
| Pubmed | Fgf9 signalling stimulates Spred and Sprouty expression in embryonic mouse pancreas mesenchyme. | 5.37e-08 | 23 | 156 | 5 | 20934536 | |
| Pubmed | 5.37e-08 | 23 | 156 | 5 | 19770068 | ||
| Pubmed | 5.37e-08 | 23 | 156 | 5 | 21223962 | ||
| Pubmed | FGF signaling regulates the number of posterior taste papillae by controlling progenitor field size. | 6.75e-08 | 24 | 156 | 5 | 21655085 | |
| Pubmed | 6.75e-08 | 24 | 156 | 5 | 12421715 | ||
| Pubmed | 8.01e-08 | 10 | 156 | 4 | 15784911 | ||
| Pubmed | 8.01e-08 | 10 | 156 | 4 | 12956878 | ||
| Pubmed | 8.01e-08 | 10 | 156 | 4 | 8450224 | ||
| Pubmed | 8.01e-08 | 10 | 156 | 4 | 15470137 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 31189094 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 28056982 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 8382556 | ||
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 20371654 | ||
| Pubmed | Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. | 8.85e-08 | 3 | 156 | 3 | 16815190 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 10609818 | ||
| Interaction | FGF6 interactions | 1.16e-07 | 7 | 155 | 4 | int:FGF6 | |
| Interaction | FGF18 interactions | 1.16e-07 | 7 | 155 | 4 | int:FGF18 | |
| Interaction | FGF5 interactions | 2.30e-07 | 8 | 155 | 4 | int:FGF5 | |
| Interaction | FGF23 interactions | 2.30e-07 | 8 | 155 | 4 | int:FGF23 | |
| Interaction | KLB interactions | 1.59e-06 | 12 | 155 | 4 | int:KLB | |
| Interaction | KL interactions | 3.17e-06 | 14 | 155 | 4 | int:KL | |
| Interaction | FGF7 interactions | 5.70e-06 | 16 | 155 | 4 | int:FGF7 | |
| Interaction | FGF9 interactions | 5.70e-06 | 16 | 155 | 4 | int:FGF9 | |
| Interaction | CRLF2 interactions | 7.36e-06 | 61 | 155 | 6 | int:CRLF2 | |
| Interaction | FGF1 interactions | 2.15e-05 | 44 | 155 | 5 | int:FGF1 | |
| Interaction | FGF17 interactions | 2.15e-05 | 44 | 155 | 5 | int:FGF17 | |
| Interaction | DGCR2 interactions | 8.12e-05 | 181 | 155 | 8 | int:DGCR2 | |
| Interaction | DNM3 interactions | 9.85e-05 | 96 | 155 | 6 | int:DNM3 | |
| Cytoband | 6p21.3 | 2.55e-05 | 250 | 156 | 7 | 6p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 1.18e-04 | 139 | 156 | 5 | chr5p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q31 | 1.22e-04 | 140 | 156 | 5 | chr7q31 | |
| Cytoband | 7q22 | 2.98e-04 | 38 | 156 | 3 | 7q22 | |
| Cytoband | 2p22-p21 | 3.17e-04 | 8 | 156 | 2 | 2p22-p21 | |
| Cytoband | 8p12 | 5.59e-04 | 47 | 156 | 3 | 8p12 | |
| Cytoband | 6p23 | 1.17e-03 | 15 | 156 | 2 | 6p23 | |
| Cytoband | 2p22.1 | 1.33e-03 | 16 | 156 | 2 | 2p22.1 | |
| Cytoband | 5p13.1 | 1.69e-03 | 18 | 156 | 2 | 5p13.1 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | TMIGD1 MXRA5 NRCAM PDGFRA MFAP3L LRRN3 UNC5C CNTN3 FGFR1 FGFR3 FGFR2 FGFR4 UNC5D ALPK2 MYBPC2 | 1.88e-14 | 161 | 103 | 15 | 593 |
| GeneFamily | C1-set domain containing | 1.31e-07 | 42 | 103 | 6 | 591 | |
| GeneFamily | Fibronectin type III domain containing | 3.28e-07 | 160 | 103 | 9 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.06e-06 | 40 | 103 | 5 | 321 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.95e-06 | 44 | 103 | 5 | 588 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.80e-04 | 8 | 103 | 2 | 939 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 8.80e-04 | 8 | 103 | 2 | 281 | |
| GeneFamily | Plexins | 1.13e-03 | 9 | 103 | 2 | 683 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.40e-03 | 10 | 103 | 2 | 830 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.86e-03 | 394 | 103 | 8 | 471 | |
| GeneFamily | Ankyrin repeat domain containing | 2.62e-03 | 242 | 103 | 6 | 403 | |
| GeneFamily | C2 domain containing|Calpains | 3.22e-03 | 15 | 103 | 2 | 975 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.20e-03 | 57 | 103 | 3 | 1179 | |
| GeneFamily | Immunoglobulin like domain containing | 4.95e-03 | 193 | 103 | 5 | 594 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.29e-03 | 21 | 103 | 2 | 813 | |
| Coexpression | SANA_RESPONSE_TO_IFNG_UP | 6.26e-06 | 76 | 156 | 6 | M4551 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP | 6.68e-06 | 21 | 156 | 4 | M41167 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | LXN ZFYVE1 PKHD1L1 DENND4C MFAP3L BROX COL24A1 GMPR LTBP1 HERC1 NPAT | 2.02e-05 | 384 | 156 | 11 | M45735 |
| Coexpression | GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP | 2.66e-05 | 199 | 156 | 8 | M9480 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_1000 | TMIGD1 PDK4 HLA-E STAP2 CD55 EVPL MFAP3L ADGRG6 MSMB ESRP2 LMO7 CARD6 FGFR3 CAPN5 OSMR ARAP2 AHNAK2 | 2.18e-05 | 736 | 152 | 17 | gudmap_developingLowerUrinaryTract_adult_ureter_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_200 | 3.72e-05 | 174 | 152 | 8 | gudmap_kidney_adult_RenalCapsule_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | PRRX1 GBP6 PDGFRA CD55 GPC6 GBP4 LMO7 PTPRQ PLXNA4 C7 OSMR AHNAK2 | 3.90e-05 | 408 | 152 | 12 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | PRRX1 PDGFRA VEZT BARD1 GPC6 MFAP3L STAT5B HSPA13 SETDB1 CPLANE1 VPS13B | 7.33e-05 | 369 | 152 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | PDK4 CAPN1 STARD10 HLA-E STAP2 EVPL PRAG1 MFAP3L ADGRG6 ESRP2 LMO7 PIERCE1 MCU GMPR FGFR3 CAPN5 OSMR PLK3 ARAP2 | 8.37e-05 | 987 | 152 | 19 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.65e-05 | 148 | 152 | 7 | gudmap_kidney_adult_RenCorpuscGlomer_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | PDGFRA GPC6 STAT5B HSPA13 BROX SETDB1 STOX2 RESF1 TTC7B ZNF770 CPLANE1 | 1.40e-04 | 397 | 152 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_top-relative-expression-ranked_1000 | TMIGD1 PDK4 CAPN1 HLA-E CD55 EVPL MFAP3L ADGRG6 ESRP2 LMO7 CARD6 FGFR3 CAPN5 OSMR ARAP2 AHNAK2 | 1.50e-04 | 778 | 152 | 16 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.63e-04 | 161 | 152 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 1.74e-04 | 217 | 152 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.80e-04 | 218 | 152 | 8 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.92e-04 | 280 | 152 | 9 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | DOCK4 PRRX1 PDGFRA CD55 SCRN1 GPC6 UNC5C LTN1 PLXNA4 LTBP1 FGFR1 | 2.18e-04 | 418 | 152 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NRCAM VEZT SCRN1 ZFYVE1 DENND4C HSPA13 STOX2 PLEKHM2 KIF13A GMPPB IL36G | 2.23e-04 | 419 | 152 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K1 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.12e-09 | 200 | 154 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-08 | 182 | 154 | 9 | d996ceb77c83591df4cef144ca72862f31d9777f | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.21e-08 | 190 | 154 | 9 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 3.02e-08 | 197 | 154 | 9 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-08 | 197 | 154 | 9 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.02e-08 | 197 | 154 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.02e-08 | 197 | 154 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.29e-08 | 199 | 154 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.29e-08 | 199 | 154 | 9 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-07 | 169 | 154 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-07 | 181 | 154 | 8 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-07 | 184 | 154 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-07 | 184 | 154 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-07 | 184 | 154 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-07 | 189 | 154 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.23e-07 | 189 | 154 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-07 | 191 | 154 | 8 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-07 | 191 | 154 | 8 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-07 | 192 | 154 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.79e-07 | 193 | 154 | 8 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.79e-07 | 193 | 154 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.79e-07 | 193 | 154 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.94e-07 | 194 | 154 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.94e-07 | 194 | 154 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-07 | 195 | 154 | 8 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-07 | 195 | 154 | 8 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.10e-07 | 195 | 154 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-07 | 195 | 154 | 8 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 195 | 154 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-07 | 195 | 154 | 8 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.26e-07 | 196 | 154 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 4.26e-07 | 196 | 154 | 8 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.43e-07 | 197 | 154 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.43e-07 | 197 | 154 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.43e-07 | 197 | 154 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.43e-07 | 197 | 154 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-07 | 198 | 154 | 8 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.60e-07 | 198 | 154 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 4.60e-07 | 198 | 154 | 8 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-07 | 199 | 154 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-07 | 199 | 154 | 8 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.78e-07 | 199 | 154 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.78e-07 | 199 | 154 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.78e-07 | 199 | 154 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-07 | 199 | 154 | 8 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-07 | 199 | 154 | 8 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.96e-07 | 200 | 154 | 8 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.96e-07 | 200 | 154 | 8 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-07 | 200 | 154 | 8 | cee07d9370656e1c428a7a9e9fbd175129901374 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 160 | 154 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 160 | 154 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-06 | 172 | 154 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-06 | 177 | 154 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 178 | 154 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.28e-06 | 181 | 154 | 7 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-06 | 183 | 154 | 7 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-06 | 185 | 154 | 7 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-06 | 185 | 154 | 7 | 01d0e848d8ede2745cfb10b070e2d9674ef4d477 | |
| ToppCell | |World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 121 | 154 | 6 | da8fe561dcf50792d0cbcaad383d564f900a6677 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.06e-06 | 187 | 154 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.21e-06 | 188 | 154 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.21e-06 | 188 | 154 | 7 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.36e-06 | 189 | 154 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 189 | 154 | 7 | 0c612ff5f882f2d8ec744a347780bbbe7cc471bd | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.36e-06 | 189 | 154 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 4.36e-06 | 189 | 154 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.36e-06 | 189 | 154 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 189 | 154 | 7 | bc8949bd4f425ed36e2c05e653c94cb1593c5bee | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 191 | 154 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.67e-06 | 191 | 154 | 7 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 191 | 154 | 7 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.67e-06 | 191 | 154 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.67e-06 | 191 | 154 | 7 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-06 | 192 | 154 | 7 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-06 | 192 | 154 | 7 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-06 | 192 | 154 | 7 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-06 | 192 | 154 | 7 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.83e-06 | 192 | 154 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.83e-06 | 192 | 154 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-06 | 192 | 154 | 7 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-06 | 192 | 154 | 7 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-06 | 192 | 154 | 7 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 192 | 154 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-06 | 193 | 154 | 7 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.00e-06 | 193 | 154 | 7 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.00e-06 | 193 | 154 | 7 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 5.00e-06 | 193 | 154 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 5.00e-06 | 193 | 154 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.00e-06 | 193 | 154 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-06 | 194 | 154 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-06 | 194 | 154 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-06 | 194 | 154 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.17e-06 | 194 | 154 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.17e-06 | 194 | 154 | 7 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.17e-06 | 194 | 154 | 7 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.17e-06 | 194 | 154 | 7 | 889c6e231bdd5b59902c7d2afdc077360b1d3256 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-06 | 195 | 154 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-06 | 195 | 154 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 5.35e-06 | 195 | 154 | 7 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| Computational | Genes in the cancer module 199. | 1.23e-05 | 57 | 98 | 6 | MODULE_199 | |
| Computational | RTK signaling. | 5.80e-05 | 46 | 98 | 5 | MODULE_259 | |
| Computational | Genes in the cancer module 85. | 9.58e-05 | 51 | 98 | 5 | MODULE_85 | |
| Computational | Genes in the cancer module 293. | 1.52e-04 | 12 | 98 | 3 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 2.49e-04 | 14 | 98 | 3 | MODULE_143 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 2.01e-09 | 4 | 154 | 4 | ctd:C568950 | |
| Drug | Palifermin | 2.99e-08 | 6 | 154 | 4 | DB00039 | |
| Drug | Heparitin Sulfate | 1.38e-06 | 29 | 154 | 5 | ctd:D006497 | |
| Drug | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 3.44e-06 | 16 | 154 | 4 | ctd:C561052 | |
| Drug | ponatinib | 6.73e-06 | 68 | 154 | 6 | ctd:C545373 | |
| Drug | BDP_X | 7.21e-06 | 40 | 154 | 5 | CID000978607 | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 7.81e-06 | 196 | 154 | 9 | 832_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 8.82e-06 | 199 | 154 | 9 | 7326_DN | |
| Drug | lumiracoxib | 1.04e-05 | 7 | 154 | 3 | ctd:C473384 | |
| Drug | Palladium | 1.04e-05 | 7 | 154 | 3 | ctd:D010165 | |
| Drug | Oligosaccharides | 3.63e-05 | 28 | 154 | 4 | ctd:D009844 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.35e-05 | 188 | 154 | 8 | 6451_DN | |
| Drug | SU4984 | 4.55e-05 | 2 | 154 | 2 | DB02058 | |
| Drug | 2-propylpentanoic acid; Up 200; 10000uM; HL60; HG-U133A | 4.69e-05 | 190 | 154 | 8 | 410_UP | |
| Drug | Heparin | 4.78e-05 | 140 | 154 | 7 | ctd:D006493 | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 5.24e-05 | 193 | 154 | 8 | 3614_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 5.63e-05 | 195 | 154 | 8 | 5591_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.84e-05 | 196 | 154 | 8 | 4948_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 5211_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 5250_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 2328_UP | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; PC3; HT_HG-U133A | 6.05e-05 | 197 | 154 | 8 | 5805_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 6.27e-05 | 198 | 154 | 8 | 251_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 1655_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 1862_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 6.27e-05 | 198 | 154 | 8 | 3970_UP | |
| Drug | PD 166285 | 6.38e-05 | 12 | 154 | 3 | CID005311382 | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.50e-05 | 199 | 154 | 8 | 2302_UP | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 6.50e-05 | 199 | 154 | 8 | 311_DN | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 4579_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 6.73e-05 | 200 | 154 | 8 | 5513_UP | |
| Drug | chlorate | 7.24e-05 | 103 | 154 | 6 | CID000019654 | |
| Drug | PD173074 | 7.90e-05 | 65 | 154 | 5 | CID000001401 | |
| Drug | nitrobenzyl-DOTA | 8.95e-05 | 35 | 154 | 4 | CID000129949 | |
| Drug | Heparan Sulfate Proteoglycans | 1.05e-04 | 14 | 154 | 3 | ctd:D019812 | |
| Drug | PD 173074 | 1.05e-04 | 14 | 154 | 3 | ctd:C115711 | |
| Disease | bone disease (implicated_via_orthology) | 3.20e-09 | 5 | 150 | 4 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Lacrimoauriculodentodigital syndrome | 1.29e-07 | 3 | 150 | 3 | C0265269 | |
| Disease | Levy-Hollister syndrome | 1.29e-07 | 3 | 150 | 3 | cv:C0265269 | |
| Disease | Congenital hypoplasia of radius | 1.29e-07 | 3 | 150 | 3 | C0685381 | |
| Disease | TWIST1-related craniosynostosis | 5.13e-07 | 4 | 150 | 3 | cv:C4551902 | |
| Disease | Cleft upper lip | 1.59e-06 | 39 | 150 | 5 | C0008924 | |
| Disease | Cleft palate, isolated | 2.32e-06 | 42 | 150 | 5 | C1837218 | |
| Disease | high grade glioma (implicated_via_orthology) | 2.94e-06 | 44 | 150 | 5 | DOID:3070 (implicated_via_orthology) | |
| Disease | Craniosynostosis syndrome | 4.44e-06 | 7 | 150 | 3 | cv:C0010278 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 2.06e-05 | 11 | 150 | 3 | DOID:0080822 (is_implicated_in) | |
| Disease | JACKSON-WEISS SYNDROME | 2.57e-05 | 2 | 150 | 2 | C0795998 | |
| Disease | FGFR2-related craniosynostosis | 2.57e-05 | 2 | 150 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 2.57e-05 | 2 | 150 | 2 | 101600 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 2.57e-05 | 2 | 150 | 2 | C1852406 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 2.57e-05 | 2 | 150 | 2 | C2931888 | |
| Disease | Isolated coronal synostosis | 2.57e-05 | 2 | 150 | 2 | cv:CN043619 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 2.57e-05 | 2 | 150 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | Jackson-Weiss syndrome | 2.57e-05 | 2 | 150 | 2 | cv:C0795998 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 2.57e-05 | 2 | 150 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 2.57e-05 | 2 | 150 | 2 | cv:C0220658 | |
| Disease | JACKSON-WEISS SYNDROME | 2.57e-05 | 2 | 150 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 2.57e-05 | 2 | 150 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 2.57e-05 | 2 | 150 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | Cleft Palate | 5.96e-05 | 81 | 150 | 5 | C0008925 | |
| Disease | autistic disorder (is_implicated_in) | 6.18e-05 | 42 | 150 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | Craniofacial dysostosis type 1 | 7.68e-05 | 3 | 150 | 2 | C2931196 | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 7.68e-05 | 3 | 150 | 2 | DOID:639 (is_implicated_in) | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 7.68e-05 | 3 | 150 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 7.68e-05 | 3 | 150 | 2 | C0220658 | |
| Disease | Saethre-Chotzen Syndrome | 7.68e-05 | 3 | 150 | 2 | C0175699 | |
| Disease | Brachycephaly | 8.31e-05 | 17 | 150 | 3 | C0221356 | |
| Disease | lupus nephritis (is_implicated_in) | 9.93e-05 | 18 | 150 | 3 | DOID:0080162 (is_implicated_in) | |
| Disease | amino acid metabolic disorder (implicated_via_orthology) | 1.53e-04 | 4 | 150 | 2 | DOID:9252 (implicated_via_orthology) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.57e-04 | 157 | 150 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | HLA-DRB1 HLA-DRB4 HLA-E GRM4 ITGAM BRCA2 FGFR1 FGFR2 HTR3B CSMD1 | 1.73e-04 | 477 | 150 | 10 | C0005586 |
| Disease | Schizophrenia | DOCK4 RAPGEF6 HLA-DRB1 HLA-E GRM4 ITGAM GRM8 SETDB1 UNC5C FGFR1 FGFR2 HTR3B CSMD1 PLXNA2 | 1.74e-04 | 883 | 150 | 14 | C0036341 |
| Disease | blood pressure | 1.85e-04 | 22 | 150 | 3 | EFO_0004325 | |
| Disease | PR interval | DOCK4 KIF13B PRRX1 GRM8 GJD4 TRPM3 MACF1 FGFR1 FGFR2 SLC2A11 | 2.33e-04 | 495 | 150 | 10 | EFO_0004462 |
| Disease | Diffuse Scleroderma | 2.54e-04 | 5 | 150 | 2 | C1258104 | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 2.54e-04 | 5 | 150 | 2 | EFO_0801672 | |
| Disease | pancreatic cancer (is_implicated_in) | 2.75e-04 | 112 | 150 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | Allergic Reaction | 3.03e-04 | 63 | 150 | 4 | C1527304 | |
| Disease | Hypersensitivity | 3.22e-04 | 64 | 150 | 4 | C0020517 | |
| Disease | susceptibility to hepatitis B infection measurement | 3.22e-04 | 64 | 150 | 4 | EFO_0008405 | |
| Disease | Polydactyly | 3.37e-04 | 117 | 150 | 5 | C0152427 | |
| Disease | prostate cancer (is_implicated_in) | 3.37e-04 | 117 | 150 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 3.80e-04 | 6 | 150 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | CREST Syndrome | 3.80e-04 | 6 | 150 | 2 | C0206138 | |
| Disease | hypospadias (biomarker_via_orthology) | 3.80e-04 | 6 | 150 | 2 | DOID:10892 (biomarker_via_orthology) | |
| Disease | glucagon measurement, glucose tolerance test | 3.80e-04 | 6 | 150 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | zinc finger protein 276 measurement | 3.80e-04 | 6 | 150 | 2 | EFO_0802227 | |
| Disease | extranodal nasal NK/T cell lymphoma | 3.80e-04 | 6 | 150 | 2 | MONDO_0019472 | |
| Disease | Scleroderma, Limited | 3.80e-04 | 6 | 150 | 2 | C0748540 | |
| Disease | Autistic Disorder | 3.93e-04 | 261 | 150 | 7 | C0004352 | |
| Disease | regulator of G-protein signaling 8 measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0801997 | |
| Disease | uroplakin-3b-like protein measurement | 5.30e-04 | 7 | 150 | 2 | EFO_0802204 | |
| Disease | MASA syndrome (implicated_via_orthology) | 5.30e-04 | 7 | 150 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Disproportionate short stature | 6.51e-04 | 77 | 150 | 4 | C0878659 | |
| Disease | tumor necrosis factor receptor superfamily member 3 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0020813 | |
| Disease | desmoglein-1 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0020321 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0801373 | |
| Disease | chromobox protein homolog 5 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0020258 | |
| Disease | kallikrein-6 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0801739 | |
| Disease | interleukin-21 measurement | 7.04e-04 | 8 | 150 | 2 | EFO_0801724 | |
| Disease | epididymal-specific lipocalin-10 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0801576 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0007790 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 1 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0020342 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0020296 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0801463 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 9.03e-04 | 9 | 150 | 2 | EFO_0009824 | |
| Disease | mast cell-expressed membrane protein 1 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0801787 | |
| Disease | interleukin-34 measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0020505 | |
| Disease | central nervous system non-hodgkin lymphoma | 9.03e-04 | 9 | 150 | 2 | MONDO_0044887 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0801686 | |
| Disease | heterogeneous nuclear ribonucleoprotein q measurement | 9.03e-04 | 9 | 150 | 2 | EFO_0020443 | |
| Disease | cataract (implicated_via_orthology) | 9.53e-04 | 38 | 150 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.12e-03 | 10 | 150 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | postburn hypertrophic scarring severity measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0007747 | |
| Disease | DNA repair protein rad51 homolog 1 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0020330 | |
| Disease | tropomyosin beta chain measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0020787 | |
| Disease | hydroxyproline measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0010498 | |
| Disease | CCL19 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0009415 | |
| Disease | Holoprosencephaly sequence | 1.12e-03 | 10 | 150 | 2 | cv:C0079541 | |
| Disease | Head and Neck Carcinoma | 1.12e-03 | 10 | 150 | 2 | C3887461 | |
| Disease | interleukin-37 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0020506 | |
| Disease | insulin growth factor-like family member 3 measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0801700 | |
| Disease | Immature Reticulocyte Fraction Measurement | 1.12e-03 | 10 | 150 | 2 | EFO_0009253 | |
| Disease | susceptibility to plantar warts measurement | 1.17e-03 | 90 | 150 | 4 | EFO_0008406 | |
| Disease | Congenital small ears | 1.19e-03 | 41 | 150 | 3 | C0152423 | |
| Disease | Prostatic Neoplasms | 1.26e-03 | 616 | 150 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.26e-03 | 616 | 150 | 10 | C0376358 | |
| Disease | liver cirrhosis (is_implicated_in) | 1.37e-03 | 43 | 150 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | interleukin-10 receptor subunit alpha measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0021890 | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 1.37e-03 | 11 | 150 | 2 | EFO_0801640 | |
| Disease | type 1 diabetes mellitus | 1.53e-03 | 242 | 150 | 6 | MONDO_0005147 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.56e-03 | 45 | 150 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | craniosynostosis (is_implicated_in) | 1.64e-03 | 12 | 150 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | Spina Bifida | 1.64e-03 | 12 | 150 | 2 | C0080178 | |
| Disease | complement component C7 measurement | 1.64e-03 | 12 | 150 | 2 | EFO_0008093 | |
| Disease | Status Dysraphicus | 1.64e-03 | 12 | 150 | 2 | C0038219 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVPSCLKAATQGVVE | 116 | Q9NWW7 | |
| CETVSQKDVYLPKAT | 581 | Q9BXX2 | |
| VVCPVSDILYKGETI | 336 | P54687 | |
| EVVTPEKVCKNYLTS | 296 | Q99728 | |
| DSGYKILDPSSITCV | 1591 | Q96PZ7 | |
| TAGQICLYSITVPKE | 1646 | Q96PZ7 | |
| PVDKYSPQEICSVDT | 826 | Q86TB3 | |
| GSATVKYVPSVVCLQ | 96 | P35670 | |
| GTIENYKPIQVVSAC | 141 | O95264 | |
| NYETVPCDSTISKVI | 271 | Q86SQ4 | |
| TCTVYAIKTRGVPET | 766 | Q14833 | |
| TQEGPLYVIVECAAK | 541 | P22455 | |
| TQGSDVCEPKYQTVS | 191 | P51684 | |
| AGQCIDPYITVSVKD | 181 | Q96BJ3 | |
| QSQAVVTPEKCGYLE | 581 | Q8WZ64 | |
| VPTVGFCVETVEYKN | 46 | Q8IVW1 | |
| PSIINYDDESGKTCV | 221 | Q3KP44 | |
| DSPTGANSYVIIKCE | 531 | O15484 | |
| ITPVYCTGVSAQVQK | 6 | P07384 | |
| LSAVVIGKCPYSQEA | 326 | Q9BUB4 | |
| DITGSSDPYCIVKVD | 21 | O43374 | |
| KLVEEGTNVTICYVS | 156 | Q99650 | |
| DITGSSDPYCIVKVD | 21 | C9J798 | |
| PTPTCFDEAQKVIYT | 166 | Q08116 | |
| TVDVLYTVCNPVGKV | 181 | Q8WVV9 | |
| CTERDTETVKGVLPY | 91 | O94822 | |
| SANVTPCVSKDGGYI | 836 | Q14207 | |
| QGIIEYKDACTVDPV | 136 | Q16654 | |
| TFTVGPYICEATVKG | 181 | P16234 | |
| VVPSDKGNYTCVVEN | 221 | P21802 | |
| KCQRGIEGTVPYVTT | 651 | Q5SY16 | |
| VYLEKSIVTGPDNCI | 101 | Q5BN46 | |
| AAVVVPSGEEQRYTC | 266 | P13747 | |
| TEPAVTHDKNTCIIY | 391 | O75121 | |
| LGAVYCSTVVPSDDV | 61 | Q8NE86 | |
| CSTVVPSDDVTVVYQ | 66 | Q8NE86 | |
| ETVPRSGEVYTCQVE | 191 | Q30154 | |
| EIPVAQKDSTGTYTC | 511 | Q92823 | |
| VTEIPCGDVYTVMVS | 681 | Q5VTL7 | |
| TKVEEPSKYGVVVCE | 136 | Q9Y5P6 | |
| PSKYGVVVCEADTGR | 141 | Q9Y5P6 | |
| QTGDAPIVSETCEVY | 361 | Q15751 | |
| ITYKCEESFVKIPGE | 61 | P08174 | |
| TGVVDCYVSRPTEKS | 181 | Q96KN9 | |
| SIKAQGATGEVYCPS | 746 | Q9H1B7 | |
| YTVLIGETPCAVTVS | 1181 | O75051 | |
| YTVLVGEKPCTVTVS | 1181 | Q9HCM2 | |
| VISEEKGPCYRLVSS | 671 | Q14766 | |
| SDEYVCSRPLVGKQT | 1531 | Q14766 | |
| GNCTYVLVEEISPSV | 4501 | Q02817 | |
| QDVGVTCPEQDKYRT | 161 | P05164 | |
| PIAGIYDTTTDNKCS | 1826 | Q92817 | |
| EITYTVPADKCGLVI | 356 | Q96I24 | |
| KSPLQVYCEAEGVTD | 636 | Q5VZ66 | |
| KCVPYAVIEGAVRSV | 61 | Q969V5 | |
| PTVQGTSKSSCYLEE | 371 | Q8WWI1 | |
| GVPKVTYTEFCQGRT | 266 | Q86W50 | |
| EVICTGKQLTEYPLD | 36 | Q8N7C0 | |
| VVTYVDAINSGAVPC | 311 | Q96PP9 | |
| AVTYVEAINSGAVPC | 296 | Q6ZN66 | |
| DVVYCSLPEVGTKLN | 81 | P23434 | |
| PLNIVITEGCVSKYS | 1611 | Q96RT7 | |
| PTQERYKDGVVTIGC | 351 | P36915 | |
| CVVGGYLSPKTVADT | 251 | Q9NQG6 | |
| TLVSTPVGYDKDNCQ | 71 | P08118 | |
| LTSQDIDCIAYTKGP | 66 | Q9NPF4 | |
| VTCTVYAIKTRGVPE | 761 | O00222 | |
| VKNITIEGVAYTSEC | 276 | A8MWY0 | |
| VQETYCETSGKLPSE | 2951 | Q9UPN3 | |
| ASPVQFYKVCVSVVS | 236 | Q9Y2X0 | |
| VITGPTCYLIDVKSV | 1606 | Q9UMZ3 | |
| KTSGCYGPIQVEFVS | 1291 | O14522 | |
| ETVPRSGEVYTCQVE | 191 | P79483 | |
| EPQSLCYVFGTGTKV | 91 | B9A064 | |
| VTPVTVAVITCKYPE | 51 | Q9NZH8 | |
| VAVITCKYPEALEQG | 56 | Q9NZH8 | |
| ALPYTICKDESVTAG | 401 | Q9Y625 | |
| PEAKIQYAIIGTGSC | 306 | Q9BYW1 | |
| TPEVTLSYSVEKVGC | 171 | Q9BX69 | |
| LSYSVEKVGCEVPAT | 176 | Q9BX69 | |
| EKVGCEVPATITYIK | 181 | Q9BX69 | |
| CIGKTVESQLYTNPD | 811 | Q8N1I0 | |
| SSILCGTEKPEVYIE | 536 | P49917 | |
| SDVPVKTNIEVCSTY | 2201 | P51587 | |
| LEAVVCEEPQVKYST | 231 | Q8TCZ2 | |
| ITENYSGQKTCVFPT | 2791 | Q9H799 | |
| SEIVGYEIKPTETTC | 961 | Q8TD57 | |
| VPSDKGNYTCIVENE | 221 | P11362 | |
| GYTDEPVSKILCQVE | 476 | O75912 | |
| YGTDGCPVSVEKIVN | 251 | P55211 | |
| KPFYTVGEKVTVSCS | 646 | P10643 | |
| KSAGETVPEGYTCVE | 51 | Q5VZ89 | |
| ETVPRSGEVYTCQVE | 191 | P01911 | |
| QKENCPYVITSGITE | 596 | O43303 | |
| ETVPRSGEVYTCQVE | 191 | P13762 | |
| KVQTDPSGIYIATSC | 666 | O60336 | |
| TAASIGQYEVVKECV | 41 | Q6ZW76 | |
| IVCDSKYSDIEPSTG | 181 | A4D0S4 | |
| CYVPVITEEVGSSLE | 151 | O43174 | |
| CPYSILEITSVEIGV | 106 | O15520 | |
| PKVIGIDLGTTYCSV | 31 | P48723 | |
| PVPAETGSKEVVCYS | 131 | Q7Z589 | |
| ESVVPSDRGNYTCVV | 216 | P22607 | |
| KTGVGYPQLSAVIEC | 191 | P36959 | |
| GQCYSKKSVVPESDT | 21 | P0DO97 | |
| TIKCDVYIETPDTGG | 561 | P54803 | |
| EGTLQPYQKTVITFC | 331 | Q6ZTR5 | |
| VEPSDVGNYTCVVTS | 186 | Q9P232 | |
| ISAVSTEPGKEYCVL | 921 | Q8IWE5 | |
| CGVTYEIVSNIPKAT | 1301 | Q9H1H9 | |
| VKVNCTAEVLYPSTG | 66 | Q9BS40 | |
| NGEYCPVEVISAKDV | 1001 | Q9NQT8 | |
| EKVNTATTTVYRCGP | 321 | A2RTX5 | |
| NEKVNTPTTTVYRCG | 241 | P26639 | |
| CTYSAVVKAPSGVQV | 216 | Q9HAU8 | |
| PKYVIDVEQPFSCTS | 211 | Q9UGK3 | |
| DTYSLCEVSVTPEGV | 791 | Q8TEU7 | |
| TGPKSCVITYLAQVD | 176 | Q9Y365 | |
| APTDIESGTVYDCVK | 71 | Q8IVB4 | |
| VTPKEGGLYTCIATN | 486 | Q9H3W5 | |
| ETVYPVIKEGSVCSL | 786 | Q9HCM1 | |
| VVTCTVQGESKALIY | 271 | Q15572 | |
| VTVKETYCSVTNLVP | 426 | A1L4K1 | |
| VPCESATAKAVDGYV | 686 | P51692 | |
| EVIKQKYETGPCSDS | 226 | Q9H6T0 | |
| GPTVHQTCSENTYVK | 106 | P11215 | |
| ELTPINGTEETLCYK | 11 | Q96LB2 | |
| CGKTIESIQLSPEEY | 351 | O15091 | |
| KVECTYISIDQVPRT | 51 | Q12765 | |
| DITYGKEDVPLSCVN | 681 | Q15047 | |
| YGVVTGPSASKICND | 21 | Q5VW32 | |
| PCEDVTLTKYQVTVP | 4786 | Q8IVF2 | |
| CGKKYFSTETIPEVQ | 181 | Q17RW2 | |
| DTETGSAYAVKVIPQ | 81 | Q9H4B4 | |
| DSIQIKVKDVPTAYC | 411 | Q8N2E2 | |
| SITKVEKPDNGTYSC | 181 | Q6UXZ0 | |
| YSNLVTVGCQVTKPD | 81 | Q3ZCX4 | |
| YKEVCIPEIVSGSKE | 551 | Q9P2F5 | |
| GVPVKTAEYTSITDC | 1561 | Q9HCF6 | |
| ESVAIVCSPKFQETG | 361 | O95630 | |
| DAEGYVKPQSCIDIV | 81 | O75425 | |
| VPVECYKVSLGKTDA | 476 | Q9BTF0 | |
| IGVYPEQGDCVISKV | 1201 | Q14683 | |
| VDCSVPVSVSTSIKY | 66 | Q9P0W8 | |
| NKVTIGSYPCVVEES | 1596 | Q86WI1 | |
| YALTGEPITDCAVKQ | 676 | Q6UXZ4 | |
| ATCSEDPGSTYAVKI | 1011 | Q86YV5 | |
| GYCSKVQTGITAAEP | 356 | Q96BW9 | |
| CNTEGISSVVQPDKY | 156 | Q9NZQ9 | |
| CQAPGVQKYEVSESD | 561 | Q6IQ21 | |
| EVFKTSPTQESCTVG | 206 | Q9HBF4 | |
| SNLVSVGYCVHKPEV | 46 | Q06730 | |
| YIGIGKPAEATACTQ | 706 | Q86TV6 | |
| PIVSIGFYCTKATVT | 386 | Q7Z7G8 | |
| CTKETQELVSEAYPI | 456 | Q9HBM0 | |
| KSYSGDVTAVEQPIV | 166 | P54821 | |
| KQITSYGETCPGLEQ | 421 | P50990 | |
| VVVVGEENFTTPCYI | 636 | O95185 | |
| QVTISELCKTYDLPG | 136 | O94874 | |
| ITSVYGCSRQEPVVE | 286 | Q8IU80 | |
| EGVSCLSKVYVTLPE | 1206 | Q9Y493 | |
| VQVPYGDVVTVACEA | 2356 | Q9NR99 | |
| YTIKVTNPVGEDVAS | 616 | Q14324 |